The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
Background: Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, and in over 80% of cases, antibodies are identified against the nicotinic type of acetylcholine receptor (AChR) on the muscle endplate. Despite the availability of various treatment options, patients wi...
Main Authors: | Pawan T Ojha, Abhijeet M Gaikwad, Rakesh Singh, Kamlesh Jagiasi, Shashank Nagendra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=395;epage=400;aulast=Ojha |
Similar Items
-
Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
by: Sudulagunta, Sreenivasa Rao, et al.
Published: (2016-10-01) -
Rituximab treatment in myasthenia gravis
by: Ana Vesperinas-Castro, et al.
Published: (2023-10-01) -
Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
by: Chao Huang, et al.
Published: (2022-07-01) -
FoxP3− Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines
by: Huanyu Meng, et al.
Published: (2021-12-01) -
Antigen specific B cells in myasthenia gravis patients
by: Kazushiro Takata, et al.
Published: (2020-04-01)